Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Phase 1 Completed 10 enrolled USWM, LLC (dba US WorldMeds)

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the relative exposures of lofexidine and its major metabolites in subjects seeking buprenorphine dose reduction.

Timeline

Start: 2016-06
Primary completion: 2016-08
Completion: 2016-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lofexidine	Small molecule	0.8 mg	—

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Summary

Timeline

Drugs

Indications